PROPRANOLOL TEVA L P 160 mg, extended-release capsule 90 capsules
Active ingredients: Propranolol hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release capsule90 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROPRANOLOL TEVA L P 160 mg, gélule à libération prolongée
- Pharmaceutical form
- gélule à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC aluminium de 90 gélule(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Jul 2008
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63077978CIP73723118CIP133400937231183Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PROPRANOLOL (CHLORHYDRATE DE)gélule | 160 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.